Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data
Sara Sáez-Atiénzar(The Ohio State University), Silvia Peverelli(IRCCS Istituto Auxologico Italiano), Ruili Huang(National Institutes of Health), Ruth Chia(National Institutes of Health), Selina N. Beal(University of Sheffield), Ileana Lorenzini(Banner Sun Health Research Institute), Ramita Dewan(National Institutes of Health), Menghang Xia(National Center for Advancing Translational Sciences), Ceren Tunca(Koç University), Cleide Dos Santos Souza(University of Sheffield), Elif Bayraktar(Koç University), Viviana Pensato(Fondazione IRCCS Istituto Neurologico Carlo Besta), Ashley Jones(Johns Hopkins University), Joke J.F.A. van Vugt(University Medical Center Utrecht), Jinhui Ding(National Institutes of Health), Lucia Corrado(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Wouter van Rheenen(King's College London), Camelia Burciu(Barrow Neurological Institute), Adriano Chiò(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Jennifer Lévy(Barrow Neurological Institute), J. Raphael Gibbs(National Institutes of Health), William Camu(Hôpital Gui de Chauliac)
Cited by 6
Related Papers
A reference panel of 64,976 haplotypes for genotype imputation
|Nature Genetics|2016|3.3k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
The transcriptional landscape of age in human peripheral blood
|Nature Communications|2015|774
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
|Neuron|2018|724